Pharmacovigilance in palliative care

Debra Rowett, David Currow

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)


    Patients receiving palliative care are at high risk of adverse effects from drugs. As these effects can be difficult to distinguish from the symptoms of the terminal illness, harm from medicines is often not recognised.

    Adverse effects can contribute to the burden of symptoms, at a time when good control of symptoms is paramount. Adding another drug to treat the adverse effects can compound the problem.

    Patients should be asked about their symptoms as they may not volunteer the information or recognise the link with their medicines. Reviewing their treatment may prompt a change in dose, drug or lead to some treatments being stopped.

    Original languageEnglish
    Pages (from-to)204-209
    Number of pages6
    JournalAustralian Prescriber
    Issue number6
    Publication statusPublished - 1 Dec 2014


    • Adverse effects
    • Opioids


    Dive into the research topics of 'Pharmacovigilance in palliative care'. Together they form a unique fingerprint.

    Cite this